AP

US adds second COVID-19 pill, this time from Merck

Dec 23, 2021, 7:59 AM | Updated: Aug 2, 2022, 12:35 pm
FILE - This undated photo provided by Merck & Co. shows their new antiviral medication molnupir...
FILE - This undated photo provided by Merck & Co. shows their new antiviral medication molnupiravir. U.S. regulators have authorized a second pill against COVID-19, an antiviral drug from Merck that may help blunt the wave of infections driven by the omicron variant. The Food and Drug Administration granted the drug emergency use Thursday, Dec. 23, 2021, for adults with early COVID-19 who face the highest risks of hospitalization.(Merck & Co. via AP, File)
(Merck & Co. via AP, File)

WASHINGTON (AP) — U.S. health regulators on Thursday authorized the second pill against COVID-19, providing another easy-to-use medication to battle the rising tide of omicron infections.

The Food and Drug Administration authorization of Merck’s molnupiravir comes one day after the agency cleared a competing drug from Pfizer. That pill, Paxlovid, is likely to become the first-choice treatment against the virus, thanks to its superior benefits and milder side effects.

As a result, Merck’s pill is expected to have a smaller role against the pandemic than predicted just a few weeks ago. Its ability to head off severe COVID-19 is much smaller than initially announced and the drug label will warn of serious safety issues, including the potential for birth defects.

The Food and Drug Administration authorized Merck’s drug for adults with early symptoms of COVID-19 who face the highest risks of hospitalization, including older people and those with conditions like obesity and heart disease. The U.K. first authorized the pill in early November.

Known as molnupiravir, the Merck drug will carry a warning against use during pregnancy. Women of childbearing age should use birth control during treatment and for a few days after while men should use birth control for at least three months after their final dose, the FDA said.

The restrictions were expected after an FDA advisory panel only narrowly endorsed the drug last month, warning that its use would have to be strictly tailored to patients who can benefit the most.

The Pfizer pill works differently and doesn’t carry the same risks. Additionally, Pfizer’s drug was roughly three times more effective in testing, reducing hospitalization and death by nearly 90% among high-risk patients, compared with 30% for Merck’s.

Some experts question whether there will be much of a role for the Merck drug in the U.S.

“To the extent that there’s an ample supply of Pfizer’s pill, I think it won’t be used,” said Dr. Gregory Poland of the Mayo Clinic, referring to the Merck drug. “There would be no reason, given it has less efficacy and a higher risk of side effects.”

For now, the FDA decision provides another potential option against the virus that has killed more than 800,000 Americans, even as health officials brace for record-setting cases, hospitalizations, and deaths driven by the omicron variant. Antiviral pills, including Merck’s, are expected to be effective against omicron because they don’t target the spike protein where most of the variant’s worrisome mutations reside.

The FDA based its decision on results showing nearly 7% of patients taking the drug ended up in the hospital and one died at the end of 30 days. That compared with 10% of patients hospitalized who were taking the placebo and nine deaths.

Federal officials have agreed to purchase enough of the drug to treat 3.1 million people.

The U.S. will pay about $700 for each course of Merck’s drug, which requires patients to take four pills twice a day for five days. A review by Harvard University and King’s College London estimated it costs about $18 to make each 40-pill course of treatment.

Merck’s drug inserts tiny errors into the coronavirus’ genetic code to slow its reproduction. That genetic effect has raised concerns that the drug could cause mutations in human fetuses and even spur more virulent strains of the virus. But FDA scientists said the variant risk is largely theoretical because people take the drug for such a short period of time.

The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Department of Science Education. The AP is solely responsible for all content.

Today’s Top Stories

AP

supreme court pictured, its new term has started and will hear new cases...
The Associated Press

Supreme Court’s top cases for new term, new Justice Jackson

Already the Supreme Court has said it will decide cases on a range of major issues including affirmative action, voting rights and the rights of LGBTQ people.
13 hours ago
TikTok shown on a phone. TikTok is proving influential in poliitics...
DAVID KLEPPER Associated Press

TikTok politics: Candidates turn to it ‘for better or worse’

TikTok isn't just about viral dance challenges anymore, but also a place to shop, learn about beauty, fashion or even politics.
4 days ago
Damage from Hurricane Ian...
ADRIANA GOMEZ-LICON Associated Press

Ian returns to hurricane status, meanwhile floods trap many in Florida

Hours after weakening to a tropical depression while crossing the Florida peninsula, Ian regained hurricane strength Thursday evening after emerging over the Atlantic Ocean.
5 days ago
An uprooted tree, toppled by strong winds from the outer bands of Hurricane Ian, rests in a parking...
CURT ANDERSON Associated Press

Ian makes landfall in southwest Florida as Category 4 storm

About 2.5 million people had been ordered to evacuate the area before the storm hit the coast on Wednesday with maximum sustained winds of 150 mph (241 kph).
6 days ago
The White House to ask for less money to fund border wall...
ACACIA CORONADO and GISELA SALOMON Associated Press

Increase in Venezuelan migration is felt across US

Last month, Venezuelans surpassed Guatemalans and Hondurans to become the second-largest nationality stopped at the U.S. border after Mexicans.
8 days ago
In Iran, protests have led to violent clashes between citizens and security forces. Protesters pict...
The Associated Press

At least 9 killed as Iran protests over woman’s death spread

The scope of Iran's ongoing unrest, the worst in several years, still remains unclear as protesters in more than a dozen cities.
11 days ago

Sponsored Articles

Young woman receiving laser treatment...
Form Derm Spa

How facial plastic surgery and skincare are joining forces

Facial plastic surgery is not only about looking good but about feeling good too. The medical team at Form Spa are trained to help you reach your aesthetic outcomes through surgery and through skincare and dermatology, too.
large group of friends tohether in a park having fun...
BYU MBA at the Marriott School of Business

What differentiates BYU’s MBA program from other MBA programs

Commitment to service is at the heart of BYU’s MBA program, which makes it stand out among other MBA programs across the country.
a worker with a drill in an orange helmet installs a door in the house...
Price's Guaranteed Doors

Home improvement tip: Increase the value of your home by weatherproofing doors

Make sure your home is comfortable before the winter! Seasonal maintenance keeps your home up to date. Read our tips on weatherproofing doors.
Curb Appeal...
Price's Guaranteed Doors

How to have the best of both worlds for your house | Home security and curb appeal

Protect your home and improve its curb appeal with the latest security solutions like beautiful garage doors and increased security systems.
A paper reading IRS, internal revenue service is pictured...
Jordan Wilcox

The best strategies for dealing with IRS tax harassment | You have options!

Learn how to deal with IRS tax harassment. This guide will teach you how to stop IRS phone calls and letters, and how to handle an IRS audit.
spend a day at Bear Lake...
Bear Lake Convention and Visitors Bureau

You’ll love spending the day at Bear Lake | How to spend a day at Bear Lake

Bear Lake is a place that needs to be experienced. Spend a day at Bear Lake.
US adds second COVID-19 pill, this time from Merck